US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Cerevel Therapeutics Holdings, Inc.

18.07

0.0000

Volume:- -

Turnover:- -

Market Cap:- -

PE:- -

High:18.07

Open:18.07

Low:18.07

Close:18.07

Loading ...

Overview Company News Filings

Cerevel Therapeutics Announces Redemption of Public Warrants

Cerevel Therapeutics to Report Second Quarter 2021 Financial Results on Wednesday, August 11, 2021

Cerevel Therapeutics Announces Pricing of $350 Million Public Offering of Common Stock

Gabrielle Greene-Sulzberger Is The Independent Director of Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE) And They Just Picked Up 148% More Shares

Simply Wall St.

Cerevel Therapeutics Announces Fast Track Designation Granted by the U.S. FDA to CVL-871 for the Treatment of Dementia-Related Apathy

Cerevel Therapeutics Reports First Quarter 2021 Financial Results and Business Updates

Cerevel Therapeutics to Report Fourth Quarter and Full Year 2020 Financial Results on Wednesday, March 24, 2021

What Kind Of Investors Own Most Of Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE)?

Simply Wall St.

Cerevel Therapeutics Announces Third Quarter 2020 Financial Results and Key Business Highlights

Cerevel Therapeutics to Present at Upcoming Virtual Investor Conferences

Cerevel Therapeutics Announces First Patients Dosed in all Phase 3 Trials of Tavapadon for the Treatment of Parkinson’s Disease

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/CEREW/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CEREW","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CEREW\",,,,,undefined,":{"symbol":"CEREW","market":"US","secType":"STK","nameCN":"Cerevel Therapeutics Holdings, Inc.","latestPrice":18.07,"timestamp":1630353600000,"preClose":18.07,"halted":3,"volume":0,"delay":0,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Halted","change":0,"latestTime":"07-21 16:40:00 EDT","open":18.07,"high":18.07,"low":18.07,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1753142400000},"marketStatusCode":4,"adr":0,"exchange":"NASDAQ","adjPreClose":18.07,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CEREW\",,,,,undefined,":{"symbol":"CEREW","floatShares":0,"roa":"--","roe":"--","lyrEps":0,"shares":0,"dividePrice":0,"high":18.07,"amplitude":0,"preClose":18.07,"low":18.07,"week52Low":1.5,"pbRate":"--","week52High":20.07,"institutionHeld":0,"latestPrice":18.07,"eps":0,"divideRate":0,"volume":0,"delay":0,"ttmEps":0,"open":18.07,"prevYearClose":5.65},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CEREW\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2155613023","title":"Cerevel Therapeutics Announces Redemption of Public Warrants","url":"https://stock-news.laohu8.com/highlight/detail?id=2155613023","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2155613023?lang=en_us&edition=fundamental","pubTime":"2021-07-30 19:00","pubTimestamp":1627642800,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/fW3L52nQOWxaELXYKPqjag--~B/aD0yMDA7dz04MDA7YXBwaWQ9eXRhY2h5b24-/https://s.yimg.com/uu/api/res/1.2/Ye6Kp76DNhK0VYj3OG9vXw--~B/aD0yMDA7dz04MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/0328382de8ced6d60e6da0fbc1903d50","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/fW3L52nQOWxaELXYKPqjag--~B/aD0yMDA7dz04MDA7YXBwaWQ9eXRhY2h5b24-/https://s.yimg.com/uu/api/res/1.2/Ye6Kp76DNhK0VYj3OG9vXw--~B/aD0yMDA7dz04MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/0328382de8ced6d60e6da0fbc1903d50"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cerevel-therapeutics-announces-redemption-public-110000679.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CEREW","CERE"],"gpt_icon":0},{"id":"2153767592","title":"Cerevel Therapeutics to Report Second Quarter 2021 Financial Results on Wednesday, August 11, 2021","url":"https://stock-news.laohu8.com/highlight/detail?id=2153767592","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2153767592?lang=en_us&edition=fundamental","pubTime":"2021-07-22 19:00","pubTimestamp":1626951600,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/fW3L52nQOWxaELXYKPqjag--~B/aD0yMDA7dz04MDA7YXBwaWQ9eXRhY2h5b24-/https://s.yimg.com/uu/api/res/1.2/Ye6Kp76DNhK0VYj3OG9vXw--~B/aD0yMDA7dz04MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/0328382de8ced6d60e6da0fbc1903d50","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/fW3L52nQOWxaELXYKPqjag--~B/aD0yMDA7dz04MDA7YXBwaWQ9eXRhY2h5b24-/https://s.yimg.com/uu/api/res/1.2/Ye6Kp76DNhK0VYj3OG9vXw--~B/aD0yMDA7dz04MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/0328382de8ced6d60e6da0fbc1903d50"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cerevel-therapeutics-report-second-quarter-110000191.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CEREW","CERE"],"gpt_icon":0},{"id":"2148878630","title":"Cerevel Therapeutics Announces Pricing of $350 Million Public Offering of Common Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2148878630","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2148878630?lang=en_us&edition=fundamental","pubTime":"2021-07-02 10:09","pubTimestamp":1625191740,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cerevel-therapeutics-announces-pricing-350-015000677.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CEREW","CERE"],"gpt_icon":0},{"id":"2145968046","title":"Gabrielle Greene-Sulzberger Is The Independent Director of Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE) And They Just Picked Up 148% More Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2145968046","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2145968046?lang=en_us&edition=fundamental","pubTime":"2021-06-24 13:44","pubTimestamp":1624513460,"startTime":"0","endTime":"0","summary":"Investors who take an interest in Cerevel Therapeutics Holdings, Inc.  should definitely note that the Independent Director, Gabrielle Greene-Sulzberger, recently paid US$13.06 per share to buy US$275k worth of the stock. We reckon that's a good sign, especially since the purchase boosted their holding by 148%.See our latest analysis for Cerevel Therapeutics Holdings. The Last 12 Months Of Insider Transactions At Cerevel Therapeutics Holdings. It is good to see the recent insider purchase. We al","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/dAXiahVQEwqqpcOT8PvymQ--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://s.yimg.com/uu/api/res/1.2/fZxxC7WFAddugsI0.C6IZw--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/2b615bb0216a492e754128412857f305","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/dAXiahVQEwqqpcOT8PvymQ--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://s.yimg.com/uu/api/res/1.2/fZxxC7WFAddugsI0.C6IZw--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/2b615bb0216a492e754128412857f305"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/gabrielle-greene-sulzberger-independent-director-054420167.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["TERN","CERE","CEREW","JE","CRCT"],"gpt_icon":0},{"id":"2143756929","title":"Cerevel Therapeutics Announces Fast Track Designation Granted by the U.S. FDA to CVL-871 for the Treatment of Dementia-Related Apathy","url":"https://stock-news.laohu8.com/highlight/detail?id=2143756929","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2143756929?lang=en_us&edition=fundamental","pubTime":"2021-06-15 19:00","pubTimestamp":1623754800,"startTime":"0","endTime":"0","summary":"Fast Track is an FDA process designed to facilitate the development and expedite the review of drugs to treat serious conditions and fill an unmet medical need. The designation allows for early and more frequent communication and meetings with the FDA regarding the development of CVL-871 for the treatment of dementia-related apathy. A candidate that receives Fast Track designation is also eligible for rolling review, and potentially priority review, of the marketing application.About CVL-871CVL-","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/fW3L52nQOWxaELXYKPqjag--~B/aD0yMDA7dz04MDA7YXBwaWQ9eXRhY2h5b24-/https://s.yimg.com/uu/api/res/1.2/Ye6Kp76DNhK0VYj3OG9vXw--~B/aD0yMDA7dz04MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/0328382de8ced6d60e6da0fbc1903d50","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/fW3L52nQOWxaELXYKPqjag--~B/aD0yMDA7dz04MDA7YXBwaWQ9eXRhY2h5b24-/https://s.yimg.com/uu/api/res/1.2/Ye6Kp76DNhK0VYj3OG9vXw--~B/aD0yMDA7dz04MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/0328382de8ced6d60e6da0fbc1903d50"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cerevel-therapeutics-announces-fast-track-110000776.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CEREW","CERE"],"gpt_icon":0},{"id":"2136932808","title":"Cerevel Therapeutics Reports First Quarter 2021 Financial Results and Business Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2136932808","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2136932808?lang=en_us&edition=fundamental","pubTime":"2021-05-17 18:30","pubTimestamp":1621247400,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/fW3L52nQOWxaELXYKPqjag--~B/aD0yMDA7dz04MDA7YXBwaWQ9eXRhY2h5b24-/https://s.yimg.com/uu/api/res/1.2/Ye6Kp76DNhK0VYj3OG9vXw--~B/aD0yMDA7dz04MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/0328382de8ced6d60e6da0fbc1903d50","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/fW3L52nQOWxaELXYKPqjag--~B/aD0yMDA7dz04MDA7YXBwaWQ9eXRhY2h5b24-/https://s.yimg.com/uu/api/res/1.2/Ye6Kp76DNhK0VYj3OG9vXw--~B/aD0yMDA7dz04MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/0328382de8ced6d60e6da0fbc1903d50"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cerevel-therapeutics-reports-first-quarter-103000748.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CERE","THFF","FNLC","FFBC","FBNC","CEREW"],"gpt_icon":0},{"id":"2113457361","title":"Cerevel Therapeutics to Report Fourth Quarter and Full Year 2020 Financial Results on Wednesday, March 24, 2021","url":"https://stock-news.laohu8.com/highlight/detail?id=2113457361","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2113457361?lang=en_us&edition=fundamental","pubTime":"2021-02-24 20:00","pubTimestamp":1614168000,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/fW3L52nQOWxaELXYKPqjag--~B/aD0yMDA7dz04MDA7YXBwaWQ9eXRhY2h5b24-/https://s.yimg.com/uu/api/res/1.2/Ye6Kp76DNhK0VYj3OG9vXw--~B/aD0yMDA7dz04MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/0328382de8ced6d60e6da0fbc1903d50","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/fW3L52nQOWxaELXYKPqjag--~B/aD0yMDA7dz04MDA7YXBwaWQ9eXRhY2h5b24-/https://s.yimg.com/uu/api/res/1.2/Ye6Kp76DNhK0VYj3OG9vXw--~B/aD0yMDA7dz04MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/0328382de8ced6d60e6da0fbc1903d50"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cerevel-therapeutics-report-fourth-quarter-120000144.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CERE","CEREW"],"gpt_icon":0},{"id":"2107126712","title":"What Kind Of Investors Own Most Of Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE)?","url":"https://stock-news.laohu8.com/highlight/detail?id=2107126712","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2107126712?lang=en_us&edition=fundamental","pubTime":"2021-01-29 13:14","pubTimestamp":1611897293,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/dAXiahVQEwqqpcOT8PvymQ--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://s.yimg.com/uu/api/res/1.2/fZxxC7WFAddugsI0.C6IZw--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/2b615bb0216a492e754128412857f305","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/dAXiahVQEwqqpcOT8PvymQ--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://s.yimg.com/uu/api/res/1.2/fZxxC7WFAddugsI0.C6IZw--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/2b615bb0216a492e754128412857f305"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/kind-investors-own-most-cerevel-051453970.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CERE","CEREW"],"gpt_icon":0},{"id":"2083532174","title":"Cerevel Therapeutics Announces Third Quarter 2020 Financial Results and Key Business Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2083532174","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2083532174?lang=en_us&edition=fundamental","pubTime":"2020-11-16 19:30","pubTimestamp":1605526200,"startTime":"0","endTime":"0","summary":"Participants dosed in clinical trials for lead programs in schizophrenia, epilepsy, anxiety and Parkinson’s disease. Debuted as publicly traded entity under symbol CERE. Net proceeds of approximately $440 million raised from completed business combination transaction with ARYA Sciences Acquisition Corp II and concurrent PIPE financing. Debuted as publicly traded neuroscience company. On October 28, 2020, Cerevel began trading as a public company via one of the largest go-public transactions in t","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/fW3L52nQOWxaELXYKPqjag--~B/aD0yMDA7dz04MDA7YXBwaWQ9eXRhY2h5b24-/https://s.yimg.com/uu/api/res/1.2/Ye6Kp76DNhK0VYj3OG9vXw--~B/aD0yMDA7dz04MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/0328382de8ced6d60e6da0fbc1903d50","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/fW3L52nQOWxaELXYKPqjag--~B/aD0yMDA7dz04MDA7YXBwaWQ9eXRhY2h5b24-/https://s.yimg.com/uu/api/res/1.2/Ye6Kp76DNhK0VYj3OG9vXw--~B/aD0yMDA7dz04MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/0328382de8ced6d60e6da0fbc1903d50"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cerevel-therapeutics-announces-third-quarter-113000815.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CEREW","CERE"],"gpt_icon":0},{"id":"2080996449","title":"Cerevel Therapeutics to Present at Upcoming Virtual Investor Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2080996449","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2080996449?lang=en_us&edition=fundamental","pubTime":"2020-11-04 20:00","pubTimestamp":1604491200,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/fW3L52nQOWxaELXYKPqjag--~B/aD0yMDA7dz04MDA7YXBwaWQ9eXRhY2h5b24-/https://s.yimg.com/uu/api/res/1.2/Ye6Kp76DNhK0VYj3OG9vXw--~B/aD0yMDA7dz04MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/0328382de8ced6d60e6da0fbc1903d50","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/fW3L52nQOWxaELXYKPqjag--~B/aD0yMDA7dz04MDA7YXBwaWQ9eXRhY2h5b24-/https://s.yimg.com/uu/api/res/1.2/Ye6Kp76DNhK0VYj3OG9vXw--~B/aD0yMDA7dz04MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/0328382de8ced6d60e6da0fbc1903d50"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cerevel-therapeutics-present-upcoming-virtual-120000141.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CERE","CEREW"],"gpt_icon":0},{"id":"2079620850","title":"Cerevel Therapeutics Announces First Patients Dosed in all Phase 3 Trials of Tavapadon for the Treatment of Parkinson’s Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2079620850","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2079620850?lang=en_us&edition=fundamental","pubTime":"2020-10-30 19:00","pubTimestamp":1604055600,"startTime":"0","endTime":"0","summary":"Company developing investigational treatment for both newly diagnosed patients and those with a more advanced form of the disease in need of adjunctive therapy. “We are encouraged by the benefit-risk profile of tavapadon based on the efficacy results observed in Phase 2 trials, as well as the tolerability profile we have seen in our clinical program to date,” said Raymond Sanchez, M.D., chief medical officer of Cerevel Therapeutics. “We look forward to advancing the development of tavapadon and ","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/fW3L52nQOWxaELXYKPqjag--~B/aD0yMDA7dz04MDA7YXBwaWQ9eXRhY2h5b24-/https://s.yimg.com/uu/api/res/1.2/Ye6Kp76DNhK0VYj3OG9vXw--~B/aD0yMDA7dz04MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/0328382de8ced6d60e6da0fbc1903d50","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/fW3L52nQOWxaELXYKPqjag--~B/aD0yMDA7dz04MDA7YXBwaWQ9eXRhY2h5b24-/https://s.yimg.com/uu/api/res/1.2/Ye6Kp76DNhK0VYj3OG9vXw--~B/aD0yMDA7dz04MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/0328382de8ced6d60e6da0fbc1903d50"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cerevel-therapeutics-announces-first-patients-110000700.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CERE","ARYB","CEREW","ARYBU"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":11,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CEREW\",params:#limit:5,,,undefined,":[{"market":"US","date":"2021-08-31","symbol":"CEREW","reason":null,"defaultRemindTime":1630416600000,"announcedDate":"2021-08-30","type":"delisting","dateTimestamp":1630382400000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CEREW\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CEREW\",market:\"US\",delay:false,,,undefined,":{}}}